Remove .Net Remove 2017 Remove Report Remove Startup
article thumbnail

How To Get Your Startup Funded - Tips From Entrepreneur and Renowed Angel Investor Jason Calacanis

SoCal Tech Calendar

Tuesday, September 26, 2017 -- How To Get Your Startup Funded - Tips From Entrepreneur and Renowed Angel Investor Jason Calacanis. Jason Calacanis founded Silicon Alley Reporter, Weblogs Inc, Mahalo, and Inside.com. He turned down a $20 million offer for Silicon Alley Reporter. See [link].

Tips 100
article thumbnail

Report: The Bay Area Isn’t Bleeding Tech Workers After All

Tech.Co

Areas such as Oakland and San Francisco saw rent increases as high as 40 percent between 2015 and 2017. Plenty of workers have had enough: In the final quarter of 2017, according to real estate company Redfin , more residents left San Francisco than any other major U.S. LinkedIn’s April report on the state of the U.S.

Report 70
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Xconomy Special Report: 12 San Diego Tech Startup to Watch in 2017

Xconomy

The idea was to feature early stage companies in the region that have not attracted much attention or raised a substantial amount of startup capital. I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list.

article thumbnail

10 Negatives That Still Make Going Public A High Risk

Startup Professionals Musings

In the old days, every entrepreneur dreamed of easily taking their startup public, and making it big. Today the rate of startups going public (IPO – Initial Public Offering) is up from the dead zone, but is still half the rate of 15 years ago. Startups going public are laid open to competitors and critics.

Startup 87
article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

And once in a while, a defender uses his or her face, inadvertently, to block a ball spiked over the net. The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. STAT found the figures in Editas’s quarterly earnings report. Talk about sacrifice.

article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

Mylan bumped up the price of the EpiPen 400 percent, presidential nominee Hillary Clinton responded with a tirade against drug price hikes, and—much like when Clinton railed against drug pricing last year—biotech indexes promptly plummeted more than 3 percent. —Pfizer wasn’t done after scooping up Medivation.

Pricing 40
article thumbnail

Why 2017 Should be a Great Year to Raise Venture Capital

Both Sides of the Table

Recently Upfront Ventures published its outlook for the technology startup world and venture capital overall titled it “ WTF Happened to Winter ?” The conclusion of our report was that winter did come, but it was mild and short. This was pre-inauguration so perhaps theres some scope that people feel even worse by now — I certainly do.